0.7874
-0.0361
(-4.38%)
At close: January 24 at 4:00:00 PM EST
0.7851
-0.00
(-0.29%)
After hours: 7:57:52 PM EST
Research Analysis
Earnings Estimate
| Currency in CAD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | -- | 3 | 3 |
| Avg. Estimate | -0.13 | 0 | -0.41 | -0.47 |
| Low Estimate | -0.14 | 0 | -0.43 | -0.54 |
| High Estimate | -0.13 | 0 | -0.38 | -0.36 |
| Year Ago EPS | -0.11 | -- | -0.49 | -0.41 |
Revenue Estimate
| Currency in CAD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 5 | 1 | 6 | 6 |
| Avg. Estimate | -- | -- | -- | 1M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | 6M |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in CAD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.14 | -0.11 | -0.11 | -0.11 |
| EPS Actual | -0.11 | -0.09 | -0.1 | -0.12 |
| Difference | 0.03 | 0.02 | 0.01 | -0.02 |
| Surprise % | 22.01% | 15.89% | 9.10% | -14.90% |
EPS Trend
| Currency in CAD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.13 | 0 | -0.45 | -0.47 |
| 7 Days Ago | -0.11 | 0 | -0.41 | -0.47 |
| 30 Days Ago | -0.11 | 0 | -0.41 | -0.47 |
| 60 Days Ago | -0.11 | 0 | -0.41 | -0.45 |
| 90 Days Ago | -0.11 | 0 | -0.41 | -0.45 |
EPS Revisions
| Currency in CAD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | 2 | -- | 1 | 2 |
| Down Last 30 Days | 2 | -- | 1 | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ONCY | -21.17% | -- | 16.84% | -16.06% |
| S&P 500 | 9.90% | 11.00% | 14.01% | 13.54% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/14/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 9/19/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/21/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/14/2024 |
| Initiated | Raymond James: Outperform | 4/4/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 3/8/2024 |
Related Tickers
TLSA Tiziana Life Sciences Ltd
0.7921
-19.17%
QNRX Quoin Pharmaceuticals, Ltd.
0.3809
-7.41%
XLO Xilio Therapeutics, Inc.
0.8201
-1.12%
WINT Windtree Therapeutics, Inc.
0.1792
-2.34%
CDIO Cardio Diagnostics Holdings, Inc.
0.4594
-13.32%
ALLR Allarity Therapeutics, Inc.
1.3600
-1.42%
CNSP CNS Pharmaceuticals, Inc.
0.1058
+30.62%
VIGL Vigil Neuroscience, Inc.
2.2000
-0.90%
ALXO ALX Oncology Holdings Inc.
1.5150
-12.17%
TVGN Tevogen Bio Holdings Inc.
1.3500
+1.25%